In this study, we aimed to compare, retrospectively, the 15-day continuous hemodynamic, laboratory and clinical course of COVID 19 patients to whom we administered short-term (3 days) high-dose (1000 mg) systemic methylprednisolone with those to whom low-dose long-term (2x 40 mg) systemic methylprednisolone was administered.
Study Type
OBSERVATIONAL
Enrollment
200
short-term (3 days) high-dose (1000 mg) systemic methylprednisolone and low-dose long-term (2x 40 mg) systemic methylprednisolone
Ilke Kupeli
Istanbul, Turkey (Türkiye)
RECRUITINGC Reaktif Protein
level of C Reaktif Protein
Time frame: 15 DAYS
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.